Treatment with pegylated Interferon-Atfa-2A (PEG-IFN-Aα-2A; PEGASYS™) for patients with essential thrombocythemia (ET) and polycythemia vera (PV).

被引：0
|
作者：
Quintas-Cardama, Alfonso [1 ]
Kantarjian, Hagop [1 ]
Giles, Francis [1 ]
Cortes, Jorge [1 ]
Richie, Mary Ann [1 ]
Borthakur, Gautam [1 ]
Verstovsek, Srdan [1 ]
机构：
[1] MD Anderson Canc Ctr, Houston, TX USA
来源：
BLOOD | 2006年 / 108卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4884
引用
收藏
页码：307B / 307B
页数：1
相关论文
共 50 条
  • [1] Pegylated Interferon-ALFA-2A (PEG-IFN-α-2A; PEGASYS) Therapy Renders High Clinical and Molecular Response Rates in Patients with Essential Thrombocythemia (ET) and Polycythemia VERA (PV)
    Quintas-Cardania, Alfonso
    Kantarjian, Hagop M.
    Garcia-Manero, Guillermo
    Cortes, Jorge
    Richie, Marie Ann
    Borthakur, Gautam
    Verstovsek, Srdan
    [J]. BLOOD, 2008, 112 (11) : 246 - 246
  • [2] Histomorphological responses after therapy with pegylated interferon α-2a in patients with essential thrombocythemia (ET) and polycythemia vera (PV)
    Masarova, Lucia
    Yin, C. Cameron
    Cortes, Jorge E.
    Konopleva, Marina
    Borthakur, Gautam
    Newberry, Kate J.
    Kantarjian, Hagop M.
    Bueso-Ramos, Carlos E.
    Verstovsek, Srdan
    [J]. EXPERIMENTAL HEMATOLOGY & ONCOLOGY, 2017, 6
  • [3] Histomorphological responses after therapy with pegylated interferon α-2a in patients with essential thrombocythemia (ET) and polycythemia vera (PV)
    Lucia Masarova
    C. Cameron Yin
    Jorge E. Cortes
    Marina Konopleva
    Gautam Borthakur
    Kate J. Newberry
    Hagop M. Kantarjian
    Carlos E. Bueso-Ramos
    Srdan Verstovsek
    [J]. Experimental Hematology & Oncology, 6
  • [4] Pegylated interferon-alfa-2a (PEG-IFN-α-2A; PEGASYSTM) for essential thrombocythemia (ET) and polycythemia vera (PV):: An update of an ongoing phase II study
    Quintas-Cardama, Alfonso
    Kantarjian, Hagop
    Garcia-Manero, Guillermo
    Cortes, Jorge
    Richie, Marie Ann
    Borthakur, Gautam
    Verstovsek, Srdan
    [J]. BLOOD, 2007, 110 (11) : 1036A - 1037A
  • [5] Molecular analysis of patients with polycythemia vera or essential thrombocythemia receiving pegylated interferon α-2a
    Quintas-Cardama, Alfonso
    Abdel-Wahab, Omar
    Manshouri, Taghi
    Kilpivaara, Outi
    Cortes, Jorge
    Roupie, Anne-Laure
    Zhang, Su-Jiang
    Harris, David
    Estrov, Zeev
    Kantarjian, Hagop
    Levine, Ross L.
    Verstovsek, Srdan
    [J]. BLOOD, 2013, 122 (06) : 893 - 901
  • [6] Dynamics of Mutant Alleles in Patients with Advanced Essential Thrombocythernia (ET) or Polycythemia (PV) During Pegylated Interferon-Alfa-2A (PEG-IFN-α-2A; Pegasys) Therapy
    Quintas-Cardama, Alfonso
    Abdel-Wahab, Omar
    Levine, Ross L.
    Manshouri, Taghi
    Roupie, Anne-Laure
    Kantarjian, Hagop M.
    Verstovsek, Srdan
    [J]. BLOOD, 2011, 118 (21) : 130 - 130
  • [7] Histomorphological Responses after Therapy with Pegylated Interferon Alpha-2a in Patients with Essential Thrombocythemia (ET) and Polycythemia Vera (PV)
    Masarova, Lucia
    Yin, C. Cameron
    Cortes, Jorge E.
    Konopleva, Marina
    Borthakur, Gautam
    Newberry, Kate J.
    Kantarjian, Hagop M.
    Bueso-Ramos, Carlos E.
    Verstovsek, Srdan
    [J]. BLOOD, 2016, 128 (22)
  • [8] Use of pegylated interferon in young patients with polycythemia vera and essential thrombocythemia
    Kucine, Nicole
    Bergmann, Shayla
    Krichevsky, Spencer
    Jones, Devin
    Rytting, Michael
    Jain, Juhi
    Bennett, Carolyn M.
    Resar, Linda M. S.
    Mascarenhas, John
    Verstovsek, Srdan
    Hoffman, Ronald
    [J]. PEDIATRIC BLOOD & CANCER, 2021, 68 (03)
  • [9] High Rates of Molecular Response After Long-Term Follow-up of Patients with Advanced Essential Thrombocythemia (ET) or Polycythemia Vera (PV) Treated With Pegylated Interferon-ALFA-2A (PEG-IFN-α-2A; PEGA-SYS)
    Quintas-Cardama, Alfonso
    Levine, Ross
    Manshouri, Taghi
    Kilpivaara, Outi
    Kantarjian, Hagop M.
    Verstovsek, Srdan
    [J]. BLOOD, 2010, 116 (21) : 206 - 206
  • [10] Pegylated Interferon Alpha-2b in Patients With Polycythemia Vera and Essential Thrombocythemia in the Real World
    Sun, Yingxin
    Cai, Yifeng
    Cen, Jiannong
    Zhu, Mingqing
    Pan, Jinlan
    Wang, Qian
    Wu, Depei
    Chen, Suning
    [J]. FRONTIERS IN ONCOLOGY, 2021, 11
12345